These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. Duman RS; Tallman JF; Nestler EJ J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624 [TBL] [Abstract][Full Text] [Related]
23. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors. Liu JG; Prather PL J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665 [TBL] [Abstract][Full Text] [Related]
24. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. Alt A; Mansour A; Akil H; Medzihradsky F; Traynor JR; Woods JH J Pharmacol Exp Ther; 1998 Jul; 286(1):282-8. PubMed ID: 9655870 [TBL] [Abstract][Full Text] [Related]
25. Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells. Zhang L; Tetrault J; Wang W; Loh HH; Law PY Mol Pharmacol; 2006 Jun; 69(6):1810-9. PubMed ID: 16525132 [TBL] [Abstract][Full Text] [Related]
26. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233 [TBL] [Abstract][Full Text] [Related]
27. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Chern Y; Lai HL; Fong JC; Liang Y Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918 [TBL] [Abstract][Full Text] [Related]
28. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells. Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation. Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376 [TBL] [Abstract][Full Text] [Related]
30. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures. Siehler S; Nunn C; Zupanc GK; Hoyer D Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149 [TBL] [Abstract][Full Text] [Related]
31. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization. Clark MJ; Neubig RR; Traynor JR J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136 [TBL] [Abstract][Full Text] [Related]
32. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. Kong H; Raynor K; Yasuda K; Bell GI; Reisine T Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Yabaluri N; Medzihradsky F Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981 [TBL] [Abstract][Full Text] [Related]
34. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation. Li JG; Zhang F; Jin XL; Liu-Chen LY J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694 [TBL] [Abstract][Full Text] [Related]
35. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats. Chen F; Lawrence AJ J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763 [TBL] [Abstract][Full Text] [Related]
36. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Law PY; Hom DS; Loh HH Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114 [TBL] [Abstract][Full Text] [Related]
37. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [TBL] [Abstract][Full Text] [Related]
38. [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application]. Narita M Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):107-16. PubMed ID: 9866825 [TBL] [Abstract][Full Text] [Related]
39. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells. Bot G; Blake AD; Li S; Reisine T Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350 [TBL] [Abstract][Full Text] [Related]
40. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. Graeser D; Neubig RR Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]